Yule Catto, the Essex headquartered polymer business, has sold its pharmaceuticals division, Uquifa, to the Indian firm Vivimed Labs.
Yule will receive £35m for Urquifa, the company which makes active pharmaceutical ingredients for the wider pharma industry. It operates three manufacturing sites, two in Spain and one in Mexico, employing a total of 390 people.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
Is the 4% pension rule dead? Why the 6% rule could replace it‘Pensions are for spending’ is the new mantra now inheritance tax will apply to them from April 2027. In exclusive calculations we show how much more you can take from your pension to wind it down completely by age 90.
-
Top UK destinations for holiday let investment in 2025As staycations grow popular among Brits, we reveal the UK hotspots where buying a holiday let could drive attractive returns for property owners
